Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, Pescatore P, Fiasse R, Pelckmans P, Vlietinck R, Merlin F, Zouali H, Thomas G, Colombel JF, Hugot JP; Belgian Group of Infliximab Expanded Access Program and Fondation Jean Dausset CEPH, Paris, France. Vermeire S, et al. Among authors: rutgeerts p. Gastroenterology. 2002 Jul;123(1):106-11. doi: 10.1053/gast.2002.34172. Gastroenterology. 2002. PMID: 12105838 Free article.
Pancreatic autoantibodies in inflammatory bowel disease.
Joossens S, Vermeire S, Van Steen K, Godefridis G, Claessens G, Pierik M, Vlietinck R, Aerts R, Rutgeerts P, Bossuyt X. Joossens S, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Nov;10(6):771-7. doi: 10.1097/00054725-200411000-00012. Inflamm Bowel Dis. 2004. PMID: 15626896
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence.
Ferrante M, de Hertogh G, Hlavaty T, D'Haens G, Penninckx F, D'Hoore A, Vermeire S, Rutgeerts P, Geboes K, van Assche G. Ferrante M, et al. Among authors: rutgeerts p. Gastroenterology. 2006 May;130(6):1595-606. doi: 10.1053/j.gastro.2006.02.025. Gastroenterology. 2006. PMID: 16697723
Patients with this feature had a higher endoscopic recurrence (Rutgeerts score >/=2) at 3 months (75% vs 41%; odds ratio, 4.36; 95% confidence interval, 1.44-13.23; P = .008) and at 1 year (93% vs 59%; odds ratio, 9.80; 95% confidence interval, 1.04-92.70; P …
Patients with this feature had a higher endoscopic recurrence (Rutgeerts score >/=2) at 3 months (75% vs 41%; odds ratio, 4.36; 95 …
Pharmacogenetics in inflammatory bowel disease.
Pierik M, Rutgeerts P, Vlietinck R, Vermeire S. Pierik M, et al. Among authors: rutgeerts p. World J Gastroenterol. 2006 Jun 21;12(23):3657-67. doi: 10.3748/wjg.v12.i23.3657. World J Gastroenterol. 2006. PMID: 16773681 Free PMC article. Review.
727 results